Identifying pathophysiological bases of disease in COVID-19

por Goldin, Carla J., Vázquez, Ramiro, Polack, Fernando P., Alvarez-Paggi, Damian
Publicado 2020

Acquired Haemophilia A: A Review of What We Know

por Mingot-Castellano, María Eva, Rodríguez-Martorell, Francisco Javier, Nuñez-Vázquez, Ramiro José, Marco, Pascual
Publicado 2022

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

por Pérez-Fierro, Manuel, Castellanos-Cosano, Lizett, Hueto-Madrid, Juan Antonio, López-Jiménez, Julián, Núñez-Vázquez, Ramiro José, Machuca-Portillo, Guillermo
Publicado 2023

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells

por Civenni, Gianluca, Albino, Domenico, Shinde, Dheeraj, Vázquez, Ramiro, Merulla, Jessica, Kokanovic, Aleksandra, Mapelli, Sarah N., Carbone, Giuseppina M., Catapano, Carlo V.
Publicado 2019

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

por Vázquez, Ramiro, Riveiro, Maria E., Berenguer-Daizé, Caroline, O’Kane, Anthony, Gormley, Julie, Touzelet, Olivier, Rezai, Keyvan, Bekradda, Mohamed, Ouafik, L’Houcine
Publicado 2021

Role of the Tyrosine Phosphatase SHP-2 in Mediating Adrenomedullin Proangiogenic Activity in Solid Tumors

por Sigaud, Romain, Dussault, Nadège, Berenguer-Daizé, Caroline, Vellutini, Christine, Benyahia, Zohra, Cayol, Mylène, Parat, Fabrice, Mabrouk, Kamel, Vázquez, Ramiro, Riveiro, Maria E., Metellus, Philippe, Ouafik, L’Houcine
Publicado 2021

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

por Vázquez, Ramiro, Riveiro, María E, Astorgues-Xerri, Lucile, Odore, Elodie, Rezai, Keyvan, Erba, Eugenio, Panini, Nicolò, Rinaldi, Andrea, Kwee, Ivo, Beltrame, Luca, Bekradda, Mohamed, Cvitkovic, Esteban, Bertoni, Francesco, Frapolli, Roberta, D'Incalci, Maurizio
Publicado 2016

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations

por Riveiro, Maria E., Astorgues-Xerri, Lucile, Vazquez, Ramiro, Frapolli, Roberta, Kwee, Ivo, Rinaldi, Andrea, Odore, Elodie, Rezai, Keyvan, Bekradda, Mohamed, Inghirami, Giorgio, D'Incalci, Maurizio, Noel, Kay, Cvitkovic, Esteban, Raymond, Eric, Bertoni, Francesco
Publicado 2016